Search results
Why It's A New Day For COPD Patients — And 3 Biotech Stocks
Investor's Business Daily· 19 hours agoIt's been a decade since the last innovation in treating chronic obstructive pulmonary disease, or...
Are You a Growth Investor? This 1 Stock Could Be the Perfect Pick
Zacks via Yahoo Finance· 2 days agoWhether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the...
Celebrity doctors promoted Covid vaccine without declaring payments
The Telegraph via Yahoo News· 6 days agoThe pharmaceutical watchdog has been urged to investigate after a string of celebrity doctors took...
Radioactive drugs strike cancer with precision
Knowable Magazine via Yahoo News· 1 day agoBut this number is poised to grow as major players in the biopharmaceutical industry begin to invest heavily in the technology. AstraZeneca became the...
Federal officials report more cucumber-linked Salmonella cases, second outbreak
Center for Infectious Disease Research and Policy· 2 hours agoThe CDC and FDA are also investigating a second similar Salmonella outbreak that has sickened 184...
AbbVie's (ABBV) Ovarian Cancer Therapy Meets Study Goal
Zacks via Yahoo Finance· 7 days agoData from a mid-stage study shows that treatment with AbbVie's (ABBV) Elahere achieves an objective...
Centessa Pharma Hires CFO from Fusion After AstraZeneca Takeover
Market Watch· 4 days agoPublished: June 10, 2024 at 7:37 a.m. ETShareResizeBy Dean SealCentessa Pharmaceuticals has hired the former chief financial officer of Fusion Pharmaceuticals after the latter company was acquired ...
ASCO: AffyImmune builds up foundations of autologous CAR T cell therapy
BioPharma-Reporter· 3 days agoThe US firm AffyImmune Therapeutics discusses how its donor cell-derived candidate could address...
Making Tough Decisions: A Candid Discussion Between Oncs
Medscape· 1 day agoDrs Mark Lewis and Don Dizon discuss what keeps them up at night.
Why many lung cancer patients who have never smoked have worse outcomes
Science Daily· 1 day agoThe study, published in Nature Communications, shows that lung cancer cells with two particular genetic mutations are more likely to double their genome, which helps them to withstand treatment ...